Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04533880
Other study ID # 20-00081
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 31, 2020
Est. completion date July 7, 2023

Study information

Verified date January 2024
Source NYU Langone Health
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

One of the common complaints after ACLR with BPTB autograft anterior knee pain. It is thought that this may be due to harvesting the patellar tendon for graft use. Specifically, this may be due to the bone defect that is left after graft harvesting. There is currently no consensus on a gold standard for treating the bone defect with surgeons using multiple commercially available bone void fillers as well as autologous bone graft in standard practice. The purpose of the proposed study is to evaluate the effect bone-void filler on anterior knee pain following ACL reconstruction BPTB autograft.


Recruitment information / eligibility

Status Completed
Enrollment 149
Est. completion date July 7, 2023
Est. primary completion date July 7, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients undergoing ACLR with BPTB autograft - Skeletally mature (as defined by closed growth plates on plain radiograph) - At least 18 years of age - Willing and able to provide consent Exclusion Criteria: - knee with intact ACL - skeletally immature (as defined by open physis on plain radiograph) - pregnant - less than 18 years of age - previous ACL repair or reconstruction - unable to speak english or perform informed consent - multiligamentous knee injury (two or more ligaments requiring surgical attention) - varus or valgus malalignment greater than 3 degrees

Study Design


Related Conditions & MeSH terms


Intervention

Device:
DBM
Demineralized bone matrix (Allosync, CDMB Putty, Arthrex, Naples, FL)
Calcium phosphate cement
Quickset, Arthrex, Naples, FL
Other:
Autologous bone graft
Autologous bone grafting involves utilizing bone obtained from the same individual receiving the graft

Locations

Country Name City State
United States NYU Langone Orthopedic Hospital New York New York

Sponsors (1)

Lead Sponsor Collaborator
NYU Langone Health

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Score on Knee injury and Osteoarthritis Outcome Score (KOOS) Survey The KOOS survery comprises 42 questions; questions are divided into 5 sub-categories: symptoms (7 questions), pain (9 questions), function/daily living (17 questions), function/sports and recreational activities (5 questions), quality of life (4 questions). Each item is rated on a Likert scale from 0 to 4. The score is calculated by summing the responses. The total range for each sub-category is 0-100, making the total range for the whole survey 0-500. The higher the score, the worse the symptoms and pain / higher difficulty in function. Month 12 Post-Op
Primary Score on Kujala Anterior Knee Pain Scale (AKPS) The Kujala AKPS is a 13-item screening instrument designed to assess patellofemoral pain in adolescents and young adults, with a variable ordinal response format. The total score is the sum of responses; total scores range from 0 to 100. Lower scores indicate greater signs of knee pain. Month 12 Post-Op
Primary Score on International Knee Documentation Committee (IKDC Questionnaire) The IKDC is a 10-item questionnaire evaluating knee function and symptoms. The IKDC is graded by adding the results of each item's scores, and then converting the result to a scale from 0 (lowest level of function or highest level of symptoms) to 100 points (highest level of function and lowest level of symptoms). Month 12 Post-Op
Primary VAS Score for Anterior Knee Pain The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between "no pain" and "worst pain." The total score range is 0-10; the higher the score, the worse the pain. Month 12 Post-Op
See also
  Status Clinical Trial Phase
Withdrawn NCT01433718 - Decreasing Knee Injury Risk Factors With Neuromuscular Training N/A
Recruiting NCT05395767 - LIVing Donor Allograft for Anterior Cruciate Ligament Reconstruction Study N/A
Withdrawn NCT03670550 - Dynamic ACL Brace: In Vivo Kinematics N/A
Recruiting NCT04586361 - Prospective Analysis of Introperative RegenLab PRP and Hyaluronic Acid in Patients With Knee ACL Tear Phase 4
Active, not recruiting NCT06167343 - Comparison of Semitendinosus and Quadriceps Grafts for Anterior Cruciate Ligament Reconstruction N/A
Completed NCT01727739 - Tibial Tunnel Widening in Anterior Cruciate Ligament (ACL) Reconstruction-Comparing Two Bioscrews N/A
Completed NCT03711734 - Acupuncture ACL (Anterior Cruciate Ligament) N/A
Recruiting NCT04137003 - Laval University Rouge et or Post ACL Surgery Program Effectiveness N/A
Completed NCT05876013 - Reduced Knee Flexion Strength 18 Years After ACL Reconstruction in Hamstring Group Compared to Patellar Tendon Group
Completed NCT05048420 - THE EFFECT OF RAMP LESION REPAIR ON RETURN TO SPORTS IN ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION N/A
Terminated NCT05878652 - Playmaker 3D Printed Knee Extender N/A
Recruiting NCT05542563 - Mindfulness and ACL Surgery N/A
Completed NCT02913404 - ACL-reconstruction vs ACL-reconstruction With EAT N/A
Recruiting NCT05720949 - Genicular Nerve Blocks for Anterior Cruciate Ligament Knee Surgery Phase 4
Recruiting NCT04753424 - Semitendinosus Graft as Meniscal Transplant
Not yet recruiting NCT04721119 - Comparing Adductor Canal Block and Adductor Canal Block-Local Infiltration Analgesia for Post-operative Pain Management N/A
Recruiting NCT03080402 - Mechanical Perturbation Training for ACL Injury Prevention N/A
Recruiting NCT06194682 - Anterior Cruciate Ligament Study
Enrolling by invitation NCT05161221 - Post Operative Pain Management Through Adductor Canal Block With Bupivacaine for ACL Reconstruction Phase 3
Withdrawn NCT04086030 - Blood Flow Restriction Following ACLR N/A